Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olga Mazuryk is active.

Publication


Featured researches published by Olga Mazuryk.


Journal of Inorganic Biochemistry | 2012

Interaction of apo-transferrin with anticancer ruthenium complexes NAMI-A and its reduced form.

Olga Mazuryk; Katarzyna Kurpiewska; Krzysztof Lewiński; Grażyna Stochel; Małgorzata Brindell

NAMI-A i.e. (ImH)[trans-RuCl(4)(DMSO)(Im)] (where Im is imidazole) is a ruthenium(III) complex with promising antimetastatic activity, which has been classified for II phase clinical trial. In this study, its binding properties toward apo-transferrin (apo-Tf) with regard to its hydrolytic and redox behavior are systematically investigated by the use of fluorescence spectroscopy. The reaction of NAMI-A and its reduced form with apo-Tf is proceeded by formation of aqua derivatives and the presence of at least one labile aqua ligand is sufficient to form adducts. It is found that presence of bicarbonate is not necessary for interaction of studied ruthenium complexes with apo-Tf. The calculated association constants for both NAMI-A and its reduced form are very similar with the values of 1.28 × 10(4)M(-1) and 1.36 × 10(4)M(-1) at 37 °C, respectively however, the reduced derivatives reach the equilibrium ca. 8-10 times slower. The percentage of ruthenium content in protein fractions separated from protein-unbounded ruthenium by using FPLC (fast protein liquid chromatography) method is rather high and depends on redox state of the complex, for most samples is found higher for reduced species.


European Journal of Pharmaceutical Sciences | 2017

Nitroimidazole derivatives of polypyridyl ruthenium complexes: Towards understanding their anticancer activity and mode of action

Olga Mazuryk; Oksana Krysiak-Foria; Agnieszka Żak; Franck Suzenet; Agata Ptak-Belowska; Tomasz Brzozowski; Grażyna Stochel; Małgorzata Brindell

ABSTRACT The mechanism of cell death induced by the ruthenium polypyridyl complexes comprising two 4,7‐diphenyl‐1,10‐phenanthroline ligands as well as one unmodified 2,2′‐bipyridyl or modified with 2‐nitroimidazole moiety attached by shorter (–C3H6–) or longer (–C6H12–) linker was investigated. Cytotoxicity and proliferation assays revealed that the studied Ru polypyridyl complexes are more toxic against human pancreas carcinoma PANC‐1 cell line than normal human keratinocytes HaCaT with IC50 of 3–5 &mgr;M. The Ru complexes despite accumulation in mitochondria do not lead to mitochondrial disfunction, though decreasing of mitochondrial Ca2 + causes mitochondria membrane hyperpolarization. The Ru polypyridyl conjugates induce some phenotypical characteristic of apoptosis, such as condensation of chromatin or phosphatidylserine translocation, however no caspase or calpain activation in the studied cell lines was observed, indicating that detected cell death does not occur via mitochondria‐ or ER‐activated pathways. Caspase‐independent cell death is caused by enormous ROS formation, mainly hydrogen peroxide and peroxyl radicals as well as by intracellular Ca2 + homeostasis disruption. Accumulation of the Ru compounds inhibits the completion of DNA synthesis, arresting cells in S‐phase of cell cycle. Graphical abstract Figure. No Caption available.


Coordination Chemistry Reviews | 2016

Engineering of relevant photodynamic processes through structural modifications of metallotetrapyrrolic photosensitizers

Janusz M. Dąbrowski; Barbara Pucelik; Anna Regiel-Futyra; Małgorzata Brindell; Olga Mazuryk; Agnieszka Kyzioł; Grażyna Stochel; Wojciech Macyk; Luis G. Arnaut


Journal of Biological Inorganic Chemistry | 2014

Multifaceted interplay between lipophilicity, protein interaction and luminescence parameters of non-intercalative ruthenium(II) polypyridyl complexes controlling cellular imaging and cytotoxic properties

Olga Mazuryk; Katarzyna Magiera; Barbara Rys; Franck Suzenet; Claudine Kieda; Małgorzata Brindell


Journal of Inorganic Biochemistry | 2014

2-Nitroimidazole-ruthenium polypyridyl complex as a new conjugate for cancer treatment and visualization.

Olga Mazuryk; Monika Maciuszek; Grażyna Stochel; Franck Suzenet; Małgorzata Brindell


Metallomics | 2015

The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells

Olga Mazuryk; Franck Suzenet; Claudine Kieda; Małgorzata Brindell


Coordination Chemistry Reviews | 2017

Bioinorganic antimicrobial strategies in the resistance era

Anna Regiel-Futyra; Janusz M. Dąbrowski; Olga Mazuryk; Klaudyna Śpiewak; Agnieszka Kyzioł; Barbara Pucelik; Małgorzata Brindell; Grażyna Stochel


Journal of Luminescence | 2013

Benzothiophen-pyrazine scaffold as a potential membrane targeting drug carrier

Olga Mazuryk; Elżbieta Niemiec; Grażyna Stochel; Isabelle Gillaizeau; Małgorzata Brindell


Inorganica Chimica Acta | 2016

Anticancer activity of ruthenium(II) polypyridine complexes bearing pyrrolidine substituents

Olga Mazuryk; Michał Łomzik; David Martineau; Marc Beley; Małgorzata Brindell; Grażyna Stochel; Philippe C. Gros


Journal of Inorganic Biochemistry | 2017

New ruthenium compounds bearing semicarbazone 2-formylopyridine moiety: Playing with auxiliary ligands for tuning the mechanism of biological activity

Michał Łomzik; Olga Mazuryk; Dorota Rutkowska-Zbik; Grażyna Stochel; Philippe C. Gros; Małgorzata Brindell

Collaboration


Dive into the Olga Mazuryk's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Claudine Kieda

Centre national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge